{"id":"W4308254239","doi":"10.1200/jco.21.02937","title":"Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"Regional Municipality of Durham; Lakeridge Health","funders":"MacroGenics; University of Washington","keywords":"Medicine; Trastuzumab; Oncology; Breast cancer; Internal medicine; Overall survival; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002722449,0.0005043003,0.0010504,0.0001836199,0.0002095478,0.0006251754,0.0002811588,0.0006783524,0.002347236],"category_scores_gemma":[0.001596821,0.0002612743,0.001884404,0.0001335977,0.0003709992,0.0003852524,0.0002843612,0.001311167,0.0003380025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005098119,"about_ca_system_score_gemma":0.0007886578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005151955,"about_ca_topic_score_gemma":0.002257857,"domain_scores_codex":[0.9993299,0.0004360166,0.00004899628,0.00007569914,0.00004834393,0.00006107312],"domain_scores_gemma":[0.9993243,0.000189957,0.0002210624,0.00004583738,0.00004790413,0.0001709442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9193544,0.005782581,0.00445572,0.001310347,0.003000317,0.00008053345,0.0001800092,0.0008830229,0.006376787,0.0003052785,0.002966261,0.05530473],"study_design_scores_gemma":[0.6558301,0.3077597,0.02412216,0.0002531706,0.002808075,0.0002341338,0.0000525151,0.001678508,0.001872192,0.0003365972,0.00501042,0.00004234962],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873244,0.005288199,0.0004865808,0.0007312131,0.0002929122,0.001753574,0.0006957762,0.00006975351,0.003357562],"genre_scores_gemma":[0.989176,0.002476696,0.001509135,0.001431207,0.0003518554,0.001933119,0.001270793,0.00001498695,0.00183629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002722449,"threshold_uncertainty_score":0.0143978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1259646493750785,"score_gpt":0.49088681888886,"score_spread":0.3649221695137815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}